Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo-Reference-Cited by-同舟云学术

Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo

Published:2018-02 Issue: Volume:150 Page:112-122
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Ma Julia,Zhang Xuexiang,Soloveva Veronica,Warren Travis,Guo Fang,Wu Shuo,Lu Huagang,Guo Jia,Su Qing,Shen Helen^ORCID,Solon Eric,Comunale Mary Ann,Mehta Anand,Guo Ju-Tao,Bavari Sina,Du Yanming^ORCID,Block Timothy M.,Chang Jinhong^ORCID

Funder

National Institutes of Health, USA

Unither Virology

LLC

Commonwealth of Pennsylvania

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference71 articles.

1. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay;Adcock;Antivir. Res.,2016

2. Iminosugar antivirals: the therapeutic sweet spot;Alonzi;Biochem. Soc. Trans.,2017

3. In vitro susceptibility of geographically and temporally distinct zika viruses to favipiravir and ribavirin;Baz;Antivir. Ther.,2017

4. Infectious disease. Combating emerging viral threats;Bekerman;Science,2015

5. Zika plasma viral dynamics in nonhuman primates provides insights into early infection and antiviral strategies;Best;Proc. Natl. Acad. Sci. U S A,2017

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the Complex Landscape of Ebola Infection Treatment: A Review of Emerging Pharmacological Approaches;Infectious Diseases and Therapy;2024-01

2. Preparing for the next viral threat with broad-spectrum antivirals;Journal of Clinical Investigation;2023-06-01

3. Borylated 2,3,4,5-Tetrachlorophthalimide and Their 2,3,4,5-Tetrachlorobenzamide Analogues: Synthesis, Their Glycosidase Inhibition and Anticancer Properties in View to Boron Neutron Capture Therapy;Molecules;2022-05-26

4. Inhibition of Protein N- Glycosylation Blocks SARS-CoV-2 Infection;mBio;2022-02-22

5. A yellow fever virus NS4B inhibitor not only suppresses viral replication, but also enhances the virus activation of RIG-I-like receptor-mediated innate immune response;PLOS Pathogens;2022-01-21